- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02433600
The Effect of Feeding Infant Formula With Enriched Protein Fractions in the US
March 14, 2016 updated by: Mead Johnson Nutrition
The Effect of Feeding Infant Formula With Enriched Protein Fractions
This study is intended to measure declarative or stored memory and behavior between infants who consume one of two infant formulas through approximately one year of age.
Study Overview
Status
Terminated
Conditions
Study Type
Interventional
Enrollment (Actual)
2
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Kannapolis, North Carolina, United States, 28081
- University or North Carolina Nutrition Research Instutite
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 2 months (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Singleton, 0-90 days of age at randomization
- Term infant with birth weight of a minimum of 2500 grams
- Receiving at least 75% of the recommended caloric intake from cow's milk-based infant formula
- Parent or legally authorized representative attending study visits reads, understands, and speaks English
- Signed Informed Consent and Protected Health Information authorization
Exclusion Criteria:
- History of underlying metabolic or chronic disease, congenital malformation, or immunocompromised
- Feeding difficulties or formula intolerance
- Infant born small for gestational age
- Infant born from a mother who was diabetic at childbirth
- History of seizures or neurological disorders or infant with known head/brain disease/injury
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Cow's milk-based infant formula
|
|
Experimental: Cow milk-based infant formula with enriched protein fractions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Sequence Recall using 3-dimensional props
Time Frame: 365 days of age
|
365 days of age
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Electroencephalogram response to stimuli
Time Frame: 180 days of age
|
180 days of age
|
Sequence Recall using 3-dimensional props
Time Frame: 300 days of age
|
300 days of age
|
Infant Behavior Questionnaire Revised, Short
Time Frame: 240 days of age
|
240 days of age
|
MacArthur-Bates Communication Development Inventory
Time Frame: 365 days of age
|
365 days of age
|
Bayley Scales of Infant and Toddler Development, Third Edition
Time Frame: 365 days of age
|
365 days of age
|
Achieved Weight
Time Frame: 52 weeks
|
52 weeks
|
Achieved Length
Time Frame: 52 weeks
|
52 weeks
|
Achieved Head Circumference
Time Frame: 52 weeks
|
52 weeks
|
Formula Intake
Time Frame: 52 weeks
|
52 weeks
|
Medically-confirmed Adverse Events
Time Frame: 52 weeks
|
52 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2015
Primary Completion (Actual)
October 1, 2015
Study Completion (Actual)
October 1, 2015
Study Registration Dates
First Submitted
April 27, 2015
First Submitted That Met QC Criteria
April 29, 2015
First Posted (Estimate)
May 5, 2015
Study Record Updates
Last Update Posted (Estimate)
March 16, 2016
Last Update Submitted That Met QC Criteria
March 14, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- 6035
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Declarative Memory
-
PepsiCo Global R&DUnknownChange in Cognitive Function and Fatigue During Extended Performance of the Cognitive Demand Battery (CDB) at 1, 3 and 6 Hours Post Consumption | Change in Long Term Declarative Memory at 1, 3 and 6 Hours Post-intervention.United Kingdom
-
Kutahya Health Sciences UniversityCompletedWorking Memory | The Working Memory QuestionnaireTurkey
-
Prof. Dominique de Quervain, MDClinical Trial Unit, University Hospital Basel, SwitzerlandCompletedMemory, Short-Term | Memory, Long-TermSwitzerland
-
Memorial Sloan Kettering Cancer CenterCompletedMemory Losses | Amnesia-Memory LossUnited States
-
Colorado State UniversityInstitute of Cannabis ResearchCompleted
-
University Hospital, GrenobleTIMC-IMAGUnknown
-
University Hospital, Basel, SwitzerlandCompleted
-
University of Electronic Science and Technology...CompletedOxytocin Effect on Memory Performance During Phase 1 | Oxytocin Effect on Memory Performance During Phase 2 | Oxytocin Effect on Memory Performance During Phase 3 | Oxytocin Effect on Memory Performance During Phase 4China
-
University of Maryland, College ParkUniversity of Massachusetts, AmherstRecruiting
-
Prof. Dominique de Quervain, MDNot yet recruiting
Clinical Trials on Cow's milk-based infant formula
-
Mead Johnson NutritionWithdrawnGrowthUnited States
-
Mead Johnson NutritionUniversity of Kansas Medical CenterCompletedBehavioral Measures of ToleranceUnited States
-
Ausnutria Hyproca B.V.HM hospitalesCompleted
-
Mead Johnson NutritionFederal University of BahiaCompletedChild Nutrition SciencesBrazil
-
Medical University of WarsawAusnutria Hyproca B.V.Not yet recruitingGastrointestinal Diseases | Infant Nutrition DisordersPoland
-
Mead Johnson NutritionBeijing Kangchen TechnologiesTerminated
-
Mount Sinai Hospital, CanadaMitacsRecruitingGestational Diabetes | Small for Gestational Age at Delivery | type1diabetes | Type2diabetesCanada
-
Dairy Goat Co-operative (N.Z.) LimitedKlinikum der Universität MünchenActive, not recruitingDermatitis, Atopic | Child Development | Infant Development | Eczema, InfantilePoland, Spain, Germany
-
Abbott NutritionInstitute of Child HealthCompleted